Intercontinental Exchange Inc. Common Stock vs Eli Lilly And Co — how do they compare? Intercontinental Exchange Inc. Common Stock trades at $156.69 (market cap $87.21B), while Eli Lilly And Co trades at $1,175.62 (market cap $1.04T). The key difference: Eli Lilly And Co is far larger — about 11.9× Intercontinental Exchange Inc. Common Stock's market cap, and Intercontinental Exchange Inc. Common Stock pays the higher dividend (1.34%). Which is the better fit depends on your goals.
| ICE | LLY | |
|---|---|---|
Market Cap | $87.21B | $1.04T |
Volume | 2,029,112 | 3,064,878 |
Sector | Financials | Health |
52-Week High | $175.10 | $1.28K |
52-Week Low | $122.91 | $799.57 |
Enterprise Value | $105.12B | $1.09T |
Dividend Yield | 1.34% | 0.59% |
Typical Hold Time | — | 93 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,176.69, down 1.01% on the day, amid a bullish technical outlook and strong fundamental performance. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $8.38 surpassing the $6.40 consensus. Revenue surged to $65.18B in 2025, driving a net income margin of 33.53%. Recent news highlights promising pipeline developments in weight-loss and diabetes drugs, reinforcing growth prospects.
The outlook remains positive given robust revenue growth, high profitability, and analyst consensus favoring buys. Key risks include elevated valuation multiples and competitive pressures in the pharmaceutical sector. With a consensus price target of $1,350, upside potential exists, but investors should weigh execution risks against the company's innovation pipeline.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Intercontinental Exchange provides technology and data services for financial institutions, corporations, and governments. Its businesses include exchanges and clearing, fixed-income data and analytics, and mortgage technology.
Read more on ICE →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →